# ReproducibilityPMX
Reproducibility in pharmacometrics

Workflow developed during the COVID-19 pandemic with the purpose of COVID-19 vaccination Phase III trial data analysis and support through data quality control and automated reporting (both at trial summary level, and blinded by arm, respectively) to the trial clinicians and the data safety monitoring board frequently based on continuous transfer of anonymyzed trial data updated as the trial was ongoing.

Publication under review.
